Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lobeline for smoking cessation.

L F Stead1, J R Hughes

  • 1ICRF General Practice Research Group, Division of Public Health and Primary Health Care, Institute of Health Sciences, Old Road, Headington, Oxford, UK, OX3 7LF. lindsay.stead@dphpc.ox.ac.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Glioma: from genetic to cellular heterogeneity.

Frontiers in cell and developmental biology·2024
Same author

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.

Clinical and experimental immunology·2019
Same author

Complications following laryngeal sacculectomy in brachycephalic dogs.

The Journal of small animal practice·2017
Same author

Updated guidance for writing a British Association of Dermatologists clinical guideline: the adoption of the GRADE methodology 2016.

The British journal of dermatology·2017
Same author

Football Helmet Evaluation Based on Players' EEGs.

The Physician and sportsmedicine·2016
Same author

KvSNP: accurately predicting the effect of genetic variants in voltage-gated potassium channels.

Bioinformatics (Oxford, England)·2011
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Current research indicates no long-term trials demonstrate lobeline

Area of Science:

  • Pharmacology and Addiction Research
  • Evidence-Based Medicine

Background:

  • Lobeline, a partial nicotine agonist, has been utilized in smoking cessation aids.
  • Its efficacy for long-term smoking cessation remains a subject of investigation.

Purpose of the Study:

  • To systematically review and assess the effectiveness of lobeline in achieving long-term smoking cessation.
  • Evaluate available randomized trials comparing lobeline with placebo or other interventions.

Main Methods:

  • Conducted a comprehensive search of the Cochrane Tobacco Addiction Group trials register.
  • Included randomized controlled trials with at least six months of follow-up assessing smoking cessation.
  • Extracted data on study design, lobeline dosage, and outcome measures.

Related Experiment Videos

Main Results:

  • No trials meeting the specified inclusion criteria, particularly those with long-term follow-up, were identified.
  • The available evidence base for lobeline's long-term smoking cessation effects is currently insufficient.

Conclusions:

  • There is a lack of robust evidence from long-term trials to support lobeline's efficacy in smoking cessation.
  • Further high-quality, long-term randomized controlled trials are needed to determine lobeline's role.